Literature DB >> 20885133

Behavior of coagulation factors and normal inhibitors of coagulation during the acute phase of myocardial infarction.

Ioannis Moyssakis1, Ioannis E Vlahodimitris, Meletios A Kanakis, Violetta Kapsimali, Catherine Tsoucala, George A Vaiopoulos.   

Abstract

Acute coronary syndromes are characterized by increased endothelial activation. The aim of this study was to investigate the behavior of coagulation factors V, VII, VIII and normal inhibitors antithrombin III and protein C during the acute phase of myocardial infarction. Thirty-six patients (27 men, nine women) and 35 normal individuals were studied during the acute phase of myocardial infarction, in the first 24 h. A group of 35 normal individuals was used as a control group. Blood samples were taken within the first 24 h of the hospital admission. The plasma levels of the coagulation factors were measured by the clot formation method, whereas the normal inhibitors were measured by ELISA. In the acute phase of myocardial infarction significant changes occur in coagulant and fibrinolytic factors. A decrease in plasma levels of factor V, antithrombin III and protein C was found in patients with acute myocardial infarction, compared to control group, whereas an increase in plasma levels of factor VII were observed. This study concludes that acute myocardial infarction causes consumption of fibrinolytic factors, whereas the coagulant factors seem to increase when being activated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20885133     DOI: 10.1097/MBC.0b013e32833e479a

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

Review 1.  Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells.

Authors:  Jonathan H Shannahan; Urmila P Kodavanti; Jared M Brown
Journal:  Inhal Toxicol       Date:  2012-04       Impact factor: 2.724

2.  Temporary Rise in Blood Thrombogenicity in Patients with Acute Myocardial Infarction.

Authors:  Shumpei Kosugi; Yasunori Ueda; Haruhiko Abe; Kuniyasu Ikeoka; Tsuyoshi Mishima; Tatsuhisa Ozaki; Kohtaro Takayasu; Takuya Ohashi; Haruya Yamane; Masayuki Nakamura; Takashi Fukushima; Kohei Horiuchi; Takashi Iehara; Satoshi Osaki; Kazuki Ozato; Koichi Inoue; Yukihiro Koretsune; Yasushi Matsumura
Journal:  TH Open       Date:  2021-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.